Intellectual Property India Publishes Patent Application for 'Trop2 Targeting Trispecific Protein For Treatment Of Cancer' Filed by Harpoon Therapeutics, Inc.

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517074230 A) filed by Harpoon Therapeutics, Inc., San Francisco, on Aug. 4, for 'trop2 targeting trispecific protein for treatment of cancer.'

Inventor(s) include Wesche, Holger; Lin, Shuoyen Jack; Wright, Kevin J.; and Austin, Richard J.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are TROP2 binding proteins, pharmaceutical compositions comprising such proteins or fragments thereof, as well as nucleic acids, recombinant expression vectors and host cells for making such TROP2 binding proteins. Also disclosed are methods of using the disclosed TROP2 binding proteins in the prevention, and/or treatment diseases, conditions and disorders."

The patent application was internationally filed on Dec. 14, 2023, under International application No.PCT/US2023/083985.

Disclaimer: Curated by HT Syndication.